Consistent with the finding that rFGF1ΔHBS inhibited oxidative stress and inflammation in DN, we found significantly fewer F4/80-positive macrophages and lower protein expression of CD68 in rFGF1ΔHBS-treated AN mice than in buffer-treated mice (Fig. 6a and b). This evidence concerns the gene CD68 and liver dysplastic nodule.